Literature DB >> 21252142

Estimating the impact of human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali.

LaRee Tracy1, Holly D Gaff, Colleen Burgess, Samba Sow, Patti E Gravitt, J Kathleen Tracy.   

Abstract

Human papillomavirus vaccines have potential to reduce cervical cancer incidence and mortality; however, cultural and economic barriers may hinder success in developing countries. We assessed impact of a single vaccine campaign in Mali with use of mathematical modeling. Our model shows that decreases in the prevalence of Human papillomavirus infection are proportional to achieved vaccination coverage.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21252142      PMCID： PMC3106240          DOI： 10.1093/cid/ciq190

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  14 in total

1.  Vaccine for cervical cancer: reaching adolescents in sub-Saharan Africa.

Authors:  Ann Biddlecom; Akinrinola Bankole; Kate Patterson
Journal:  Lancet       Date:  2006-04-22       Impact factor: 79.321

2.  Introducing HPV vaccine in developing countries--key challenges and issues.

Authors:  Jan M Agosti; Sue J Goldie
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

3.  The theoretical population-level impact of a prophylactic human papilloma virus vaccine.

Authors:  James P Hughes; Geoff P Garnett; Laura Koutsky
Journal:  Epidemiology       Date:  2002-11       Impact factor: 4.822

4.  Risk factors of invasive cervical cancer in Mali.

Authors:  Siné Bayo; F Xavier Bosch; Silvia de Sanjosé; Nubia Muñoz; Alba Lucia Combita; Pierre Coursaget; Mireia Diaz; Amardou Dolo; Adriaan J C van den Brule; Chris J M Meijer
Journal:  Int J Epidemiol       Date:  2002-02       Impact factor: 7.196

5.  Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes.

Authors:  G P Garnett; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1993-10-29       Impact factor: 6.237

6.  Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada.

Authors:  Ann N Burchell; Harriet Richardson; Salaheddin M Mahmud; Helen Trottier; Pierre P Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  Am J Epidemiol       Date:  2006-01-18       Impact factor: 4.897

7.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

8.  A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.

Authors:  Sue J Goldie; Daniel Grima; Michele Kohli; Thomas C Wright; Milton Weinstein; Eduardo Franco
Journal:  Int J Cancer       Date:  2003-10-10       Impact factor: 7.396

9.  Contact tracing and the estimation of sexual mixing patterns: the epidemiology of gonococcal infections.

Authors:  G P Garnett; R M Anderson
Journal:  Sex Transm Dis       Date:  1993 Jul-Aug       Impact factor: 2.830

10.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506
View more
  8 in total

1.  Portrayals of 2v, 4v and 9vHPV vaccines on Chinese social media: a content analysis of hot posts on Sina Weibo.

Authors:  Fangzhou Zhou; Wen Zhang; Hongning Cai; Yuan Cao
Journal:  Hum Vaccin Immunother       Date:  2021-09-20       Impact factor: 4.526

2.  A cross-sectional study to assess HPV knowledge and HPV vaccine acceptability in Mali.

Authors:  Danielle N Poole; J Kathleen Tracy; Lauren Levitz; Mali Rochas; Kotou Sangare; Shahla Yekta; Karamoko Tounkara; Ben Aboubacar; Ousmane Koita; Mark Lurie; Anne S De Groot
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

3.  Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models.

Authors:  Johannes A Bogaards; Mirjam Kretzschmar; Maria Xiridou; Chris J L M Meijer; Johannes Berkhof; Jacco Wallinga
Journal:  PLoS Med       Date:  2011-12-20       Impact factor: 11.069

4.  Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.

Authors:  Ibrahima Téguété; Amadou Dolo; Kotou Sangare; Abdoulaye Sissoko; Mali Rochas; Sarah Beseme; Karamoko Tounkara; Shahla Yekta; Anne S De Groot; Ousmane A Koita
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

5.  Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali.

Authors:  Anne S De Groot; Karamoko Tounkara; Mali Rochas; Sarah Beseme; Shahla Yekta; Fanta Siby Diallo; J Kathleen Tracy; Ibrahima Teguete; Ousmane A Koita
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

6.  Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts.

Authors:  Mark Jit; Carol Levin; Marc Brisson; Ann Levin; Stephen Resch; Johannes Berkhof; Jane Kim; Raymond Hutubessy
Journal:  BMC Med       Date:  2013-01-30       Impact factor: 8.775

7.  Differences in patterns of high-risk human papillomavirus infection between urban and rural low-resource settings: cross-sectional findings from Mali.

Authors:  Nicholas H Schluterman; Samba O Sow; Cheick B Traore; Kamate Bakarou; Rokiatou Dembelé; Founé Sacko; Patti E Gravitt; J Kathleen Tracy
Journal:  BMC Womens Health       Date:  2013-02-06       Impact factor: 2.809

Review 8.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.